Duchenne Muscular Dystrophy Flashcards

1
Q

Muscular dystrophy

A

Cause of muscle weakness is attributable to the pathology confined to the muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who is more affected by DMD?

A

Boys because dystrophin gene is on the X chromosome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Duchenne Muscular Dystrophy

A

Deficient dystrophin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis

A

Genetic testing
Muscle biopsy
Electromyography (EMG)
Muscle ultrasound
Blood levels of CPK (creatine phosphokinase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical presentation

A

Progression condition
Muscle weakness becomes evidence between 3-5 y/o
Developmental milestones may be delayed
Proximal muscles affected more than the distal muscle groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical presentation
- progressive condition

A

Muscle weakness
Contractures
Deformities
Progressive disability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical presentation
- Developmental milestone may be delayed

A

Bayley-III scales can show lower scores for infants and young children with DND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical presentation
- Proximal muscles

A

Shoulder and pelvic girdles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Clinical presentation
- Secondary impairments

A

Postural and gait abnormalities
Development of scoliosis
Reduced pulmonary capacity
Cardiac dysfxn
Easy fatigability
Obesity
Loss of dystrophin in the brain can cause intellectual disabilities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical Progression
- Infancy

A

Delayed motor milestone such as walking, delayed speech

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clinical progression
- Early childhood

A

Unable to keep up with peers or to climb stairs
Raises from floor using Gower’s maneuver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical progression
- From age 5 years

A

Abnormal movements (waddling gait, toe walking)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical progression
- From age 7 years

A

Walking becomes increasingly difficult
May need a scooter or wheelchair after walking long distances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical progression
- Up to 13 years

A

Loss of independent ambulation (increasing use of w/c)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical progression
- After loss of ambulation

A

Loss of self-feeding and respiratory, orthopedic, and cardiac complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical progression
- By around 20 years

A

Upper body function is lost
Become almost entirely dependent on a carer

17
Q

Clinical progression
- 30 years and beyond

A

Respiratory and cardiac failure lead to early death

18
Q

Posture

A

Shoulders and arms held back awkwardly when walking
Sway back
Weak butt muscles
Knees may bend back
Thick lower leg muscles (mostly fat)
Tight heel cord (walk on toes)
Belly sticks out d/t weak belly muscles
Thin, weak thighs
Poor balance; falls often
Weak muscles in front of the leg (foot drop) and tip-toe contractures

19
Q

Glucocorticoid use in DMD

A

Weekly treatment
Promote muscle membrane repair and muscle recovery
Delays loss of lower extremity milestones by 2-4 years, upper extremity milestone by 2.8-8 years
Reduction in risk of death

20
Q

Glucocorticoid use in DMD
- Side effects

A

Weight gain
Weak bones
High blood pressure and behavior changes
Muscle weakness and atrophy

21
Q

PT evaluation

A

Family Interview
Neuromotor development
ROM
Muscle performance and strength
Posture
Gait, locomotion and balane
Aerobic capacity and endurance
Assistive and adaptive devices
Integumentary status
Self-care and home management
Ventilation/respiration
Env’t, home, and job/school/play barriers
Community and work integration

22
Q

PT Evaluation Pt. 2

A

Pulmonary function
Ambulatory/Functional Assessment
Falls and complaints of fatigue

23
Q

PT evaluation
- pulmonary function

A

6- minute walk test

24
Q

PT evaluation
- ambulatory/functional assessment

A

Vignos functional rating scale
North star ambulatory assessment

25
Q

PT evaluation
- Falls and complaints of fatigue

A

8-10 y/o
Risk of fractures

26
Q

PT Management

A

Muscle strengthening
Prevent contractures
Adpative devices

27
Q

PT Management
- Muscle strengthening

A

Submaximal endurance exercise program
Monitor for fatigue
Strengthening abdominals, hip extensors and abductors and knee extensors

28
Q

PT Management
- Muscle strengthening–> avoid

A

Avoid resistance training, eccentric strengthening and immobilization

29
Q

PT Management
- Muscle strengthening–> exercises

A

Cycling
Swimming

30
Q

PT Management
- Prevent contractures

A

Regular stretching
Stretch gastrocnemius-soleus, HS and TFL
Stretch hip flexors when tightness is observed
Home stretching program
Night splints to reduce ankle contractures

31
Q

PT Management
- Assistive devices

A

Walker/Scooter/stroller
Motorized/manual wheelchairs
Adaptive equipment/alternate strategies for dressing, transfers, bathing, grooming, and feeding

32
Q

PT goals for adolescents with DMD

A

Submax endurance program for the upper limb
Con’t gentle stretching of lower limb muscles
After ambulation is lost
Use custom molded seating inserts, corsets, and modular seating inserts

33
Q

PT goals
- Submax endurance program for the upper limb

A

Strengthen shoulder depressors, triceps, shoulder flexors and abductors and elbow flexors

34
Q

PT goals
- Stretching of lower limbs

A

Add stretching for long finger flexors, shoulder flexors and abductors, elbow extensors, forearm supinator, and wrist extensors

35
Q

PT goals
- After ambulation is lost

A

Use a standing program with splinting to maintain bone, muscle and joint properties